Floatz logo

Therapeutic Asset Ratings

409 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Bl-M07D1
Ovarian Cancer
SystImmune Inc.P1C (36)
Bl-M17D1
Ovarian Cancer
SystImmune Inc.P1C (36)
Botensilimab
Ovarian Cancer
Agenus Inc.P1C (36)
cct303-406
Ovarian Cancer
Shanghai PerHum Therapeutics Co., Ltd.P1C (36)
cd70-targeting car-t cells
Ovarian Cancer
Chongqing Precision Biotech Co., LtdP1C (36)
cht101
Ovarian Cancer
Zhejiang UniversityP1C (36)
cirtociclib
Ovarian Cancer
Blueprint Medicines CorporationP1C (36)
Clsp-1025
Ovarian Cancer
Clasp Therapeutics, Inc.P1C (36)
CryptiVax-1001
Ovarian Cancer
Epitopea LtdP1C (36)
Cusp06
Ovarian Cancer
OnCusp Therapeutics, Inc.P1C (36)
DNA, D(P-THIO)(T-G-A-C-T-G-T-G-A-A-C-G-T-T-C-G-A-G-A-T-G-A) UNCOSASODIUM
Ovarian Cancer
PhotonPharma, Inc.P1C (36)
DPA-714
Ovarian Cancer
University of Alabama at BirminghamP1C (36)
dr-0202
Ovarian Cancer
Dren BioP1C (36)
dt2216
Ovarian Cancer
Elizabeth Stover, MD, PhDP1C (36)
exs74539
Ovarian Cancer
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.P1C (36)
Follicle Stimulating Hormone Receptor T Cells
Ovarian Cancer
H. Lee Moffitt Cancer Center and Research InstituteP1C (36)
ft536
Ovarian Cancer
Masonic Cancer Center, University of MinnesotaP1C (36)
ft836
Ovarian Cancer
Fate TherapeuticsP1C (36)
Grt-C903
Ovarian Cancer
National Cancer Institute (NCI)P1C (36)
Grt-R904
Ovarian Cancer
National Cancer Institute (NCI)P1C (36)
hs-10502
Ovarian Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.P1C (36)
HUMAN FAECAL MATTER
Ovarian Cancer
M.D. Anderson Cancer CenterP1C (36)
Hwk-007
Ovarian Cancer
Whitehawk Therapeutics, Inc.P1C (36)
ic9-car.b7-h3 t cells
Ovarian Cancer
UNC Lineberger Comprehensive Cancer CenterP1C (36)
Ide-161
Ovarian Cancer
IDEAYA BiosciencesP1C (36)
Showing 301 to 325 of 409 assets
PreviousPage 13 of 17Next